Clinical trials
Recruiting Phase 3 Carcinoma, Renal Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 2 |
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 2 |
| SWOG Cancer Research Network | 2 |
| Telix Pharmaceuticals (Innovations) Pty Limited | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Sun Yat-sen University | 1 |
| Tampere University Hospital | 1 |
| University College, London | 1 |
| Wake Forest University Health Sciences | 1 |
| Xynomic Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 14 |
| Kidney Neoplasms | 4 |
| Agnosia | 1 |
| Breast Neoplasms | 1 |
| Carcinoma | 1 |
| Ovarian Neoplasms | 1 |
| Prostatic Neoplasms | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.